NOX1 and chronic kidney disease: Serum derived from patients with early chronic kidney disease stage 2–3 or chronic kidney disease stage 5 induces NOX1 upregulation along with a robust elevation of reactive oxygen species and calcium deposition in primary rat vascular smooth muscle cells [43].